**Patient Discharge Summary**

**Patient Information:**

* Name: Jane Doe
* Date of Birth: February 12, 1965
* Admit Date: March 10, 2023
* Discharge Date: March 15, 2023
* Chief Complaint: Chest pain and shortness of breath

**Medical History:**

* The patient has no significant medical history prior to admission. She is a non-smoker, has no known allergies, and has a family history of hypertension.

**Hospital Course:**

* The patient was admitted to the cardiovascular unit on March 10, 2023, with complaints of chest pain and shortness of breath. Initial vital signs revealed a blood pressure of 160/100 mmHg, pulse rate of 90 beats per minute, and oxygen saturation of 92% on room air.
* Physical examination revealed a blood pressure of 170/110 mmHg in the right arm, 165/105 mmHg in the left arm, and a height of 5'8" and weight of 170 pounds. Waist circumference was 38 inches.
* Laboratory results showed a urinalysis with no abnormalities, lipid panel with a total cholesterol of 240 mg/dL and high-density lipoprotein (HDL) cholesterol of 40 mg/dL, metabolic panel with a creatinine of 1.2 mg/dL and blood urea nitrogen (BUN) of 15 mg/dL, fasting plasma glucose of 110 mg/dL, and thyroid-stimulating hormone (TSH) levels within normal limits.
* Electrocardiogram (ECG) showed a normal sinus rhythm with a heart rate of 80 beats per minute.
* On March 12, 2023, a 24-hour ambulatory blood pressure monitor was placed to evaluate for white coat hypertension. The monitor revealed an average blood pressure of 158/102 mmHg.
* On March 14, 2023, the patient underwent a thorough physical examination, which revealed no signs of target organ damage.
* Based on the patient's symptoms, physical examination, and laboratory results, a diagnosis of arterial hypertension was made.

**Treatment and Management:**

* The patient was started on an angiotensin-converting enzyme (ACE) inhibitor, lisinopril 20 mg orally once daily, on March 10, 2023.
* On March 12, 2023, the patient was also started on a diuretic, hydrochlorothiazide 25 mg orally once daily, to help control blood pressure.
* Lifestyle modifications were recommended, including increased physical activity, weight loss, a healthy diet, reduced sodium intake to less than 1500 mg/day, and smoking cessation.
* The patient was educated on the importance of adherence to therapy and lifestyle modifications, and was instructed on how to monitor her blood pressure at home and recognize symptoms of potential complications.

**Discharge Instructions:**

* The patient is to continue taking lisinopril 20 mg orally once daily and hydrochlorothiazide 25 mg orally once daily as directed.
* She is to follow up with her primary care physician in one week to have her blood pressure re-evaluated and medication effectiveness reassessed.
* The patient is to return to the hospital for further evaluation and treatment if she experiences any symptoms of potential complications or if her blood pressure remains uncontrolled.
* She is to continue with lifestyle modifications and monitor her blood pressure at home as instructed.

**Follow-up Plan:**

* The patient will be seen in follow-up in one week to re-evaluate her blood pressure and medication effectiveness.
* Her blood pressure will be re-evaluated every 2-3 months to assess for changes in her blood pressure and adjust her medication regimen as necessary.
* The patient will be encouraged to return to the hospital for further evaluation and treatment if she experiences any symptoms of potential complications or if her blood pressure remains uncontrolled.

**Conclusion:**

The patient was diagnosed with arterial hypertension and was started on a medication regimen consisting of an ACE inhibitor and a diuretic. Lifestyle modifications were recommended and the patient was educated on the importance of adherence to therapy and lifestyle modifications. The patient was discharged from the hospital with a plan for follow-up and ongoing management of her hypertension.